The US Food and Drug Administration has given clearance to another blood test to help assess Alzheimer’s disease and other ...

When employees hesitate, disengage, or slow adoption, leaders often blame “resistance.” Here's why they should listen to it ...

To dig deeper, the researchers developed a method for measuring activation patterns in astrocytes across a whole brain of a ...

A new twist on a classic material could advance quantum computing and make modern data centers more energy efficient, ...

In the phase 3 EMBARK trial, enzalutamide plus leuprolide and enzalutamide monotherapy were associated with longer metastasis ...

It's exam season in Australia. Year 12 students are sitting final exams, while university and younger school students also face end-of-year assessments.

After upstaging Merck & Co.’s Keytruda as a monotherapy for patients with first-line non-small cell lung cancer (NSCLC) in ...

October is Breast Cancer Awareness Month, and cancer awareness starts with general breast awareness. Dr. Julie Nangia, ...

Astellas Pharma (ALPMY) and Pfizer (PFE) announced positive results from the Phase 3 EV-303 clinical trial for PADCEV, a Nectin-4 directed ...